Fidelity Investments
CRBU icon

Fidelity Investments’s Caribou Biosciences CRBU Stock Holding History

Fidelity Investments’s Portfolio CRBU Stock Details CRBU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.38M Sell
723,959
-2,009
-0.3% -$3.45K ﹤0.01% 2758
2025
Q4 		$1.15M Sell
725,968
-3,034
-0.4% -$6.37K ﹤0.01% 2803
2025
Q3 		$1.7M Sell
729,002
-439
-0.1% -$829 ﹤0.01% 2604
2025
Q2 		$919K Sell
729,441
-730,657
-50% -$719K ﹤0.01% 2748
2025
Q1 		$1.33M Sell
1,460,098
-187,107
-11% -$243K ﹤0.01% 2583
2024
Q4 		$2.62M Buy
1,647,205
+65,712
+4% +$132K ﹤0.01% 2354
2024
Q3 		$3.1M Buy
1,581,493
+109,606
+7% +$224K ﹤0.01% 2277
2024
Q2 		$2.41M Buy
1,471,887
+26,725
+2% +$85.4K ﹤0.01% 2296
2024
Q1 		$7.43M Buy
1,445,162
+586
+0% +$3.61K ﹤0.01% 1962
2023
Q4 		$8.28M Sell
1,444,576
-619
-0% -$3.06K ﹤0.01% 1910
2023
Q3 		$6.91M Buy
1,445,195
+2,007
+0.1% +$12.5K ﹤0.01% 1940
2023
Q2 		$6.13M Sell
1,443,188
-635
-0% -$2.85K ﹤0.01% 2005
2023
Q1 		$7.67M Buy
1,443,823
+777
+0.1% +$4.84K ﹤0.01% 1972
2022
Q4 		$9.06M Sell
1,443,046
-547
-0% -$4.87K ﹤0.01% 1931
2022
Q3 		$15.2M Sell
1,443,593
-80,742
-5% -$752K ﹤0.01% 1708
2022
Q2 		$8.28M Sell
1,524,335
-488,698
-24% -$3.74M ﹤0.01% 2049
2022
Q1 		$18.5M Sell
2,013,033
-1,310,251
-39% -$13.8M ﹤0.01% 1815
2021
Q4 		$50.1M Hold
3,323,284
– – ﹤0.01% 1421
2021
Q3 		$79.3M Buy
+3,323,284
New +$81.2M 0.01% 1202

Other funds holding CRBU

P
Pfizer New York $239M AUM 232.47% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $61.9B AUM 29.81% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Fidelity Investments's CRBU Position: Q1 2026 in Review

Fidelity Investments reduced its Caribou Biosciences (CRBU) stake by 0.28% in Q1 2026, selling an estimated $3.45K and leaving 723,959 shares worth $1.38M. The position accounts for ﹤0.01% of the portfolio, ranked #2758.

Fidelity Investments first reported a position in CRBU in Q3 2021 and has held it in 19 quarters since. The position peaked at $79.3M in Q3 2021. 137 funds tracked by Wall St. Rank hold CRBU as of Q1 2026.

  • Fidelity Investments held 723,959 shares of Caribou Biosciences worth $1.38M as of Q1 2026.
  • Fidelity Investments sold 2,009 Caribou Biosciences shares in Q1 2026, an estimated $3.45K.
  • Caribou Biosciences made up ﹤0.01% of Fidelity Investments's portfolio in Q1 2026, its #2758 holding.
  • Fidelity Investments first reported a position in Caribou Biosciences in Q3 2021 and has held it in 19 quarters since.
  • Fidelity Investments's Caribou Biosciences position peaked at $79.3M in Q3 2021.
  • 137 funds tracked by Wall St. Rank held Caribou Biosciences as of Q1 2026.

Based on Fidelity Investments's 13F filing for Q1 2026, filed 15 May 2026.